MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 592915 | Name: Violantin
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Violantin is isolated from the leaves of the Indian plant Ocimum sanctum were tested for their radioprotective effect in mice.

Chemical Structure

Violantin
Violantin
CAS#23666-13-9

Theoretical Analysis

MedKoo Cat#: 592915

Name: Violantin

CAS#: 23666-13-9

Chemical Formula: C27H30O15

Exact Mass: 594.1585

Molecular Weight: 594.52

Elemental Analysis: C, 54.55; H, 5.09; O, 40.37

Price and Availability

Size Price Availability Quantity
5mg USD 550.00 2 Weeks
10mg USD 900.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
Violantin
IUPAC/Chemical Name
4H-1-Benzopyran-4-one, 6,8-di-beta-D-glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-
InChi Key
FIAAVMJLAGNUKW-VQVVXJKKSA-N
InChi Code
InChI=1S/C27H30O15/c28-6-12-17(32)21(36)23(38)26(41-12)15-19(34)14-10(31)5-11(8-1-3-9(30)4-2-8)40-25(14)16(20(15)35)27-24(39)22(37)18(33)13(7-29)42-27/h1-5,12-13,17-18,21-24,26-30,32-39H,6-7H2/t12-,13-,17-,18-,21+,22+,23-,24-,26+,27+/m1/s1
SMILES Code
O=C1C=C(C2=CC=C(O)C=C2)OC3=C([C@H]4[C@@H]([C@H]([C@@H]([C@@H](CO)O4)O)O)O)C(O)=C([C@H]5[C@@H]([C@H]([C@@H]([C@@H](CO)O5)O)O)O)C(O)=C13
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 594.52 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
J Hosp Palliat Care. 2025 Jan 4:10499091241312685. doi: 10.1177/10499091241312685. Epub ahead of print. PMID: 39754531. 2: Gamel B, Albon D, Bandla S, Davison DW, Flath J, Sabadosa KA, Seid M, Silva L, Ong T; Cystic Fibrosis Learning Network Group. Interventions to improve system-level coproduction in the Cystic Fibrosis Learning Network. BMJ Open Qual. 2024 Jul 27;13(3):e002860. doi: 10.1136/bmjoq-2024-002860. PMID: 39067867; PMCID: PMC11287073. 3: Groninger H, Violanti D, Mete M. Virtual reality for pain management in hospitalized patients with cancer: A randomized controlled trial. Cancer. 2024 Jul 15;130(14):2552-2560. doi: 10.1002/cncr.35282. Epub 2024 Apr 8. PMID: 38943468. 4: Charles LE, Gu JK, Violanti JM. Impact of Shiftwork on Retinal Vasculature Diameters over a 5-Year Period: A Preliminary Investigation Using the BCOPS Study Data. Int J Environ Res Public Health. 2024 Apr 3;21(4):439. doi: 10.3390/ijerph21040439. PMID: 38673350; PMCID: PMC11050094. 5: Rao A, Violanti D, Elliott TI, Singh M, Kim B, VandenAssem K, Sheikh FH, Groninger H. Clinical Protocol for Left Ventricular Assist Device Deactivation at End of Life. J Palliat Med. 2023 Oct;26(10):1428-1434. doi: 10.1089/jpm.2023.0176. Epub 2023 May 22. PMID: 37219893. 6: Violanti JM, Fekedulegn D, McCanlies E, Andrew ME. Proportionate mortality and national rate of death from COVID-19 among US law enforcement officers: 2020. Policing. 2022 May 24;45(5):881-891. doi: 10.1108/pijpsm-02-2022-0022. PMID: 37192870; PMCID: PMC10174272. 7: Rao A, Maini M, Anderson KM, Crowell NA, Gholami SS, Foley Lgsw C, Violanti D, Singh M, Sheikh FH, Najjar SS, Groninger H. Benefits and Harms of Continuous Intravenous Inotropic Support as Palliative Therapy: A Single-Institution, Retrospective Analysis. Am J Hosp Palliat Care. 2024 Jan;41(1):50-55. doi: 10.1177/10499091231160162. Epub 2023 Feb 22. PMID: 36812883. 8: Gu JK, Charles LE, Allison P, Violanti JM, Andrew ME. Mental Health Treatment Reported by US Workers before and during the COVID-19 Pandemic: United States (2019-2020). Int J Environ Res Public Health. 2022 Dec 30;20(1):651. doi: 10.3390/ijerph20010651. PMID: 36612970; PMCID: PMC9818999. 9: Violanti JM, Mnatsakanova A, Gu JK, Service S, Andrew ME. Adverse childhood experiences and police mental health. Policing. 2021 Oct 22;44(6):1014-1030. doi: 10.1108/pijpsm-06-2021-0085. PMID: 35928169; PMCID: PMC9345510. 10: Gu JK, Charles LE, Allison P, Violanti JM, Andrew ME. Association Between the Metabolic Syndrome and Retinal Microvascular Diameters Among Police Officers. J Occup Environ Med. 2022 Sep 1;64(9):748-753. doi: 10.1097/JOM.0000000000002569. Epub 2022 Jun 21. PMID: 35732034; PMCID: PMC10278538. 11: Gallenga CE, Franco E, Adamo GG, Violanti SS, Tassinari P, Tognon M, Perri P. Genetic Basis and Molecular Mechanisms of Uveal Melanoma Metastasis: A Focus on Prognosis. Front Oncol. 2022 Apr 11;12:828112. doi: 10.3389/fonc.2022.828112. PMID: 35480119; PMCID: PMC9037634. 12: Charles LE, Mnatsakanova A, Fekedulegn D, Violanti JM, Gu JK, Andrew ME. Associations of adverse childhood experiences (ACEs) with sleep duration and quality: the BCOPS study. Sleep Med. 2022 Jan;89:166-175. doi: 10.1016/j.sleep.2021.12.011. Epub 2021 Dec 23. PMID: 35026653; PMCID: PMC8916064. 13: Wirth MD, Fekedulegn D, Andrew ME, McLain AC, Burch JB, Davis JE, Hébert JR, Violanti JM. Longitudinal and cross-sectional associations between the dietary inflammatory index and objectively and subjectively measured sleep among police officers. J Sleep Res. 2022 Aug;31(4):e13543. doi: 10.1111/jsr.13543. Epub 2021 Dec 29. PMID: 34967055; PMCID: PMC9240102. 14: Violanti JM, Gu JK, Charles LE, Fekedulegn D, Andrew ME. Dying for the job: police mortality, 1950-2018. Policing. 2021 Oct;44(6):1168-1187. doi: 10.1108/pijpsm-06-2021-0087. PMID: 37200948; PMCID: PMC10191188. 15: McCanlies EC, Leppma M, Mnatsakanova A, Allison P, Fekedulegn D, Andrew ME, Violanti JM. Associations of burnout with awakening and diurnal cortisol among police officers. Compr Psychoneuroendocrinol. 2020 Nov;4:100016. doi: 10.1016/j.cpnec.2020.100016. PMID: 34553178; PMCID: PMC8455162. 16: Velazquez-Kronen R, Millen AE, Ochs-Balcom HM, Mnatsakanova A, Gu JK, Andrew M, Violanti J. Sleep Quality and Dietary Patterns in an Occupational Cohort of Police Officers. Behav Sleep Med. 2022 Sep-Oct;20(5):543-555. doi: 10.1080/15402002.2021.1954925. Epub 2021 Jul 25. PMID: 34304645; PMCID: PMC8786972. 17: Riedy SM, Fekedulegn D, Vila B, Andrew M, Violanti JM. Shift work and overtime across a career in law enforcement: a 15-year study. Policing. 2021 Apr 2;44(2):200-212. PMID: 34093068; PMCID: PMC8173490. 18: Gallenga CE, Lonardi M, Pacetti S, Violanti SS, Tassinari P, Di Virgilio F, Tognon M, Perri P. Molecular Mechanisms Related to Oxidative Stress in Retinitis Pigmentosa. Antioxidants (Basel). 2021 May 26;10(6):848. doi: 10.3390/antiox10060848. PMID: 34073310; PMCID: PMC8229325. 19: Violanti JM, Steege A. Law enforcement worker suicide: an updated national assessment. Policing. 2021;44(1):18-31. doi: 10.1108/PIJPSM-09-2019-0157. Epub 2020 Oct 21. PMID: 33883970; PMCID: PMC8056254. 20: Nevels TL, Burch JB, Wirth MD, Ginsberg JP, McLain AC, Andrew ME, Allison P, Fekedulegn D, Violanti JM. Shift Work Adaptation Among Police Officers: The BCOPS Study. Chronobiol Int. 2021 Jun;38(6):907-923. doi: 10.1080/07420528.2021.1895824. Epub 2021 Mar 30. PMID: 33781135; PMCID: PMC8262273.

View History

Imeglimin

Imeglimin

GSK2324

GSK2324

Visnafylline

Visnafylline

IMC-76

IMC-76

Fosfructose trisodium

Fosfructose trisodium

Bromothen

Bromothen